Drug · DIN 02455854
SANDOZ METHYLPHENIDATE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since August 1, 2019.
- Drug Identification Number (DIN)
- 02455854
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Controlled drugs (CDSA III)
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Methylphenidate N06BA04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 20, 2016: NOC 18197New Drug Submission (NDS) · Licensing agreement between two companies
Other DINs named SANDOZ METHYLPHENIDATE
- DIN 02455846 · Cancelled Pre Market